Mesa Biotech’s Accula RSV Test Receives FDA’s 510(K) Clearance and CLIA Waiver for Respiratory Infections

Shots:

• Accula RSV is second POC (point-of-care) test, to receive FDA’s 510(K) & CLIA Waiver and used additionally with nasal swab collection with disposable test cassettes
• The Accula RSV (respiratory syncytial virus) test is performed for detection of respiratory tract infections like bronchiolitis & pneumonia in adults and children
• In 2017, Sekisui Diagnostics collaborated with Mesa Biotech for commercialization of Accula RSV test as Silaris in the US and Canada

Click here to read full press release/ article | Ref: Mesa Biotech | Image: FDA News